MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Parkinson’s disease and palliative care

    A. Manna, L. Khanra (East Medinipur, India)

    Objective: As in any developing countries state of West Bengal in India has a huge burden of Parkinson patients coming from rural area where awareness…
  • 2018 International Congress

    Sing to Beat Parkinson’s®: A Group Singing Intervention for People with Parkinson’s and their Carers

    J. Irons, G. Hancox, D. Stewart (Derby, United Kingdom)

    Objective: To improve the quality of life (QoL) of People with Parkinson’s (PwP) and their carers using a group singing intervention Background: As Parkinson’s disease…
  • 2018 International Congress

    The Quality of Life of the participants in a group singing intervention for people with Parkinson’s: A comparison across China (Beijing), South Korea (Seoul) and Australia (Brisbane)

    C. Chang, Y. Irons, E. Han, S. Kim, X. Jiang, D. Stewart (Beijing, China)

    Objective: To compare the quality of life of the group participants in ‘Sing to Beat Parkinson’s® (STBP) Projects in China, S. Korea and Australia. Background:…
  • 2018 International Congress

    Incidence, prevalence and clinical features of sleep disorders in alphasynucleinopthies: A cohort study

    C. Borrue-Fernandez, J. Fernandez- Cuesta, MJ. Abenza Abildua (San Sebastian Reyes, Spain)

    Objective: Analyze the sleep disorders incidence, prevelence an clinical features depending on the time of evolution, depending on the type of alpha-synuclein, and the subtype…
  • 2018 International Congress

    REM Sleep Behavior Disorder Associations with Parkinson’s Disease Study (RAPiDS): Initial Baseline Data

    D. Barone, H. Sarva, L. Ravdin, M. Vo, A. Hanineva, M. DeGrazia, A. Krieger, N. Hellmers, C. Henchcliffe (New York, NY, USA)

    Objective: To examine association of clinical and neurophysiological characteristics associated with synucleinopathies in a cohort of adult subjects with REM sleep Behavior Disorder (RBD) and…
  • 2018 International Congress

    Sleep Abnormalities in patients with Parkinson’s disease having REM sleep behaviour disorder with and without Psychosis

    R. Yadav, V. Reddy, G. Kumar, L. George, A. Shashidharan, B. Kutty, P. Pal (Bangalore, India)

    Objective: To study the polysomnographic changes in patients of Parkinson’s disease with or without psychosis and evaluate any microarchitecture and microarchitecture changes. Background: Parkinson’s disease…
  • 2018 International Congress

    Eye tracking in patients with restless legs syndrome with and without augmentation – interim results of an ongoing study

    P. Ellmerer, B. Heim, M. Ritter, A. Stefani, E. Brandauer, E. Holzknecht, K. Seppi, B. Högl, W. Poewe, A. Djamshidian (Innsbruck, Austria)

    Objective: To assess the ability to inhibit eye movements towards a target by analysing antisaccades using an eye tracker. Background: Restless legs syndrome (RLS) is…
  • 2018 International Congress

    Genetic Markers of Essential Tremor in Restless Legs Syndrome/Willis-Ekbom Disease in Southern Chinese Population

    G. Li, HD. Tang, P. Huang, YC. He, C. Wang, XM. Qi, J. Chen, JF. Ma, SD. Chen (Shanghai, China)

    Objective: The aim of this study was to investigate the relationship between genetic markers of essential tremor and primary restless legs syndrome/Willis-Ekbom Disease (RLS/WED) in…
  • 2018 International Congress

    The prevalence and associated features of REM sleep without atonia

    F. Dijkstra, M. Viaene, I. de Volder, D. Crosiers, P. Cras (Antwerp, Belgium)

    Objective: 1. To determine the prevalence of idiopathic and secondary REM sleep without atonia (RSWA). 2. To assess excessive daytime sleepiness and depressive symptoms in…
  • 2018 International Congress

    Clonazepam for REM sleep behavior disorder in Parkinsonism: A randomized, placebo-controlled trial

    C. Shin, H. Park, W. Lee, B. Jeon, H. Kim (Seoul, Republic of Korea)

    Objective: To determine the efficacy and safety of clonazepam for the treatment of rapid eye movement (REM) sleep behavior disorder (RBD) in patients with Parkinsonism.…
  • « Previous Page
  • 1
  • …
  • 1298
  • 1299
  • 1300
  • 1301
  • 1302
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley